Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicase
- PMID: 37712848
- DOI: 10.1080/07391102.2023.2252929
Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicase
Abstract
Zika virus is responsible for causing Zika infections and was declared as a public health emergency of international concern in February 2016. The Zika virus NS3-helicase is a viable drug target for the design of inhibitors due to its essential role in the replication of viral genome. The viral RNA is unwound by the NS3-helicase in order to enable the reproduction of viral genome by the NS5 protein. Zika virus infections in humans are being reported for the last 15 years. We have therefore carried out amino acid mutational analyses of NS3-helicase. NS3-helicase has two crucial binding sites: the ATP and RNA binding sites. The cofactor-ATP based pharmacophore was generated for virtual screening of ZINC database using Pharmit server, that is followed by molecular docking and molecular dynamics simulations of potential hits as probable Zika virus NS3-helicase inhibitors at the cofactor binding site. The drug-like properties of the molecules were analysed and, DFT calculations were performed on the five best molecules to reveal their stability in solvent phase compared to gas phase, the HOMO and LUMO and electrostatic potential maps to analyze the electronic and geometric characteristics. These are significant findings towards the discovery of new inhibitors of Zika virus NS3-helicase, a promising drug target to treat the Zika virus infection.Communicated by Ramaswamy H. Sarma.
Keywords: DFT; HOMO; LUMO; Zika virus NS3-helicase; binding free energy; drug-like properties; molecular docking; molecular dynamics simulations; mutational analyses; pharmacophore.
Similar articles
-
Cellular NONO protein binds to the flavivirus replication complex and promotes positive-strand RNA synthesis.J Virol. 2024 Dec 17;98(12):e0029724. doi: 10.1128/jvi.00297-24. Epub 2024 Nov 5. J Virol. 2024. PMID: 39499073
-
Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses.Bioorg Chem. 2024 Dec;153:107914. doi: 10.1016/j.bioorg.2024.107914. Epub 2024 Nov 5. Bioorg Chem. 2024. PMID: 39546935 Review.
-
NS2B-D55E and NS2B-E65D Variations Are Responsible for Differences in NS2B-NS3 Protease Activities Between Japanese Encephalitis Virus Genotype I and III in Fluorogenic Peptide Model.Int J Mol Sci. 2024 Nov 26;25(23):12680. doi: 10.3390/ijms252312680. Int J Mol Sci. 2024. PMID: 39684391 Free PMC article.
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials